Lung Cancer Research Foundation - Minority Career Development Award

Proposals are invited for the 2022 LCRF Minority Career Development Award (CDA) in Lung Cancer, a career development award intended to support early-stage scientists from underrepresented groups working in lung cancer and working in diverse areas of research including basic, clinical, translational, disparities, and social determinants of health research. This award aims to increase the number of highly skilled and trained researchers from groups that are historically underrepresented in academia, medicine, and leadership in lung cancer research. This program aims to close the gap between the mortality rates and representation in lung cancer research by funding minority researchers.

Applications are encouraged on a wide variety of topics, including but not limited to:

• lung cancer biology;
• prevention and screening for early detection;
• identification of new biomarkers;
• development of more effective and less toxic therapies, including but not limited to targeted and immune therapies;
• genetic and gene-environment interactions;
• interactions and contributions of multiple factors (e.g., smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes;
• mechanisms of sensitivity and resistance to lung cancer therapies;
• bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy);
• and supportive measures for people with lung cancer and their families.

Eligible investigators must be from racial or ethnic groups underrepresented in health-related sciences and biomedical research. This includes African Americans or Black people, Latinos or Latinx, Native Americans or Alaskan Natives, Native Hawaiians, and other Pacific Islanders. Investigators must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators within 10 years of receiving their MD and/or PhD.